IFN-γ also enhances tumor immunogenicity by increasing MHC class I expression on tumor cells, improving antigen presentation, and activating cytotoxic CD8+ T cells to target and eliminate the tumor (67). The gene discussed is CD8A; the disease is neoplasm.